2009 H1N1 influenza, comorbidity, critically ill patient, drug efficacy, extracorporeal oxygenation, human, immunocompromised patient, letter, mortality, priority journal, survival rate
dx.doi.org/10.1093/infdis/jis638, hdl.handle.net/1765/39240
Erasmus MC: University Medical Center Rotterdam

Fraaij, P.L.A, van der Vries, E, & Osterhaus, A.D.M.E. (2013). Reply to Chan-Tack et al. doi:10.1093/infdis/jis638